CVKD vs IDXX · $20.2M cap vs P/E 40, rev $2.36B
Cadrenal Therapeutics, Inc. Common Stock (CVKD) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
CVKD does not have a complete income-statement cache yet.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
CVKD currently screens at market cap $20.2M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the CVKD and IDXX stock pages for the full models.
Not investment advice.